Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l (Q35849907)

From Wikidata
Jump to navigation Jump to search
scientific article published on 11 April 2006
edit
Language Label Description Also known as
English
Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l
scientific article published on 11 April 2006

    Statements

    Intrathecal triple therapy decreases central nervous system relapse but fails to improve event-free survival when compared with intrathecal methotrexate: results of the Children's Cancer Group (CCG) 1952 study for standard-risk acute lymphoblastic l (English)
    Yousif Matloub
    Susan Lindemulder
    Harland Sather
    Emmett Broxson
    Rochelle Yanofsky
    Raymond Hutchinson
    James Nachman
    Marilyn Blake
    Linda M Wells
    April D Sorrell
    Margaret Masterson
    John F Kelleher
    Linda C Stork
    Children's Oncology Group
    11 April 2006
    108
    1165-1173

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit